FundedIQ
Artificial Intelligence

RealRate

RealRate: Insurance Ratings based on Artificial Intelligence We have some unique characteristics, contrasting the traditional rating approach: * Independence: We do not work on behalf of the insurers * Use of artificial intelligence, enabling causal analysis of financial strength * Holistic company analysis, instead of just a bunch of key ratios * Fast and deep: our graphs let you understand a company within 2 minutes Insurance companies can purchase the RealRate seal of approval to show their customers their highly competitive market position. For insurance customers, financial strength is the most important indicator of return on their premiums paid. For brokers our rating service allows for a qualified and independent financial advice. RealRate combines a self developed expert system for insurance companies with innovative methods of artificial intelligence. We use structural neural networks to determine the causal effects of financial strengths. This allows for a fast and deep understanding of the analyzed companies, saving time and work for reading and analyzing the year-end reports, which is a difficult task. RealRate's business model is highly scalable. Reports are generated automatically. In August 2019 we published ratings of all German life insurers. There are already more than 300 rating reports available. Next steps will be German health and property/casualty insurers. The approach finally will be adapted to other countries and branches like banks, industry etc. RealRate was chosen to be one of the most promising German AI startups, see https://appliedai.de/startup-landscape-2020. RealRate is one out of eight companies in the category 'Finance and Insurance.' RealRate is part of the following international accelerators: Startupbootcamp, GSD Venture, Newchip

www.realrate.ai Santa Clara, United States 1-10 employees
Total raised
$100k
Rounds
1
Latest
Angel
Jan 2022

RealRate: Insurance Ratings based on Artificial Intelligence We have some unique characteristics, contrasting the traditional rating approach: * Independence: We do not work on behalf of the insurers * Use of artificial intelligence, enabling causal analysis of financial strength * Holistic company analysis, instead of just a bunch of key ratios * Fast and deep: our graphs let you understand a company within 2 minutes Insurance companies can purchase the RealRate seal of approval to show their customers their highly competitive market position. For insurance customers, financial strength is the most important indicator of return on their premiums paid. For brokers our rating service allows for a qualified and independent financial advice. RealRate combines a self developed expert system for insurance companies with innovative methods of artificial intelligence. We use structural neural networks to determine the causal effects of financial strengths. This allows for a fast and deep understanding of the analyzed companies, saving time and work for reading and analyzing the year-end reports, which is a difficult task. RealRate's business model is highly scalable. Reports are generated automatically. In August 2019 we published ratings of all German life insurers. There are already more than 300 rating reports available. Next steps will be German health and property/casualty insurers. The approach finally will be adapted to other countries and branches like banks, industry etc. RealRate was chosen to be one of the most promising German AI startups, see https://appliedai.de/startup-landscape-2020. RealRate is one out of eight companies in the category 'Finance and Insurance.' RealRate is part of the following international accelerators: Startupbootcamp, GSD Venture, Newchip

RealRate has raised $100k across 1 round. Its most recent round was a Angel of $100k in Jan 2022. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with plan

1 round on record.

Date
Round
Amount
Lead investor
Jan 20, 2022
Angel
$100k

Unlock the lead investor and full details for this round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

RealRate is featured in

Similar companies

Xellar Biosystems

Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.

Series A $29.5M
Taxwire

Global Sales Tax Compliance Software

Series A $25.0M
Derya

Derya is an AI-native freight-forwarding/logistics software company that provides an AI workbench for freight forwarders and related content.

Seed $1.1M
TIFIN

TIFIN is a platform that conceives, creates, and operates fintech companies in the areas of wealth management, investments, and personal finance. Their operating companies are shaping the future of investor experience with intelligent products that recognize the uniqueness of each investor. TIFIN leverages the combined power of investment intelligence, data science, and technology to make investing a more powerful driver of financial well-being.

Series Unknown
Proception
Seed $11.0M
8090 Solutions

8090 Solutions provides an AI-native software development platform through Software Factory, a system designed to help teams manage the software development lifecycle from planning to deployment. The platform connects business requirements, architecture planning, implementation tasks, testing, and feedback within a shared workspace using AI-driven workflows and knowledge management. 8090 Solutions enables organizations to coordinate product, engineering, and business teams while maintaining visibility across software projects. The company’s solutions support custom software development, AI-assisted engineering processes, and enterprise software delivery through structured collaboration between teams and AI agents.

Series A $135M
Baz

Developers no longer have to manually piece together the impact of pull requests; Baz models, analyzes and reviews code changes, detecting breaking changes, enforcing consistency, and highlighting misaligned coding patterns. Baz makes every review faster, more accurate, and aligned with the real-world impact of the code changes being made.

Seed $9.0M
Eccentric Machines

Eccentric Machines is a manufacturer of robotic actuator technology enabling advanced motion control for embodied AI systems.

Seed $5.0M
EIS Automation

EIS Automation provides modular automation and robotic solutions for manufacturing.

Series Unknown $2.0M
Pocket

Pocket is a technology company that develops an AI-enabled note-taking system combining a dedicated recording device with companion software. Its platform records in-person conversations and phone calls, transcribes audio, and organizes the content into searchable transcripts, summaries, action items, and mind maps. The system supports offline recording, cloud synchronization, and access across mobile, desktop, and web applications, with support for more than 120 languages. Pocket also provides AI-powered features for organizing, searching, and exporting recorded information while offering integrations with task management workflows. Its products are designed for individuals and teams who need to capture, organize, and retrieve information from conversations and spoken ideas.

Seed $11.0M
Straiker

Straiker builds AI-native security solutions tp protect customers from a spectrum of security & safety risks.

Series A $64.0M
Engine Biosciences

Engine Biosciences is a biotech company that uses machine learning to study genomics for the purpose of drug discovery. They are a technology company based in both San Francisco and Asia that is funded by investors. They specialize in network biomedicine and have developed their own patented technologies that involve extensive laboratory experimentation and artificial intelligence algorithms. These technologies are used for both drug discovery and cellular reprogramming. The company's research and development platform, which was created by a team of esteemed scientists and professors from universities such as MIT and Harvard, significantly speeds up and reduces the cost of developing new medical treatments. Engine Biosciences actively utilizes this platform internally and collaborates with partners in various disease areas.

Series Unknown
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.